ATC Group: R06AB03 Dimetindene

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06AB03 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R06 Antihistamines for systemic use
3 R06A Antihistamines for systemic use
4 R06AB Substituted alkylamines
5 R06AB03 Dimetindene

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 4 mg

Active ingredients in R06AB03

Active Ingredient Description
Dimetindene

Dimetindene is an antihistaminic of the alkylamine group. Its action is the result of the capture of histamine Η1 subunits. It has mild anticholinergic and sedative action.

Related product monographs

Title Information Source Document Type  
FENISTIL Oral drops, solution Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Croatia (HR)

Cyprus (CY)

Germany (DE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

Nigeria (NG)

Poland (PL)

Romania (RO)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.